x

Search for a clinical trial

* (*) mandatory field

A Double-blind, Placebo-Controlled, Randomized Withdrawal Following Open-label Therapy Study to Assess the Safety and Efficacy of Levoketoconazole (2S,4R-ketoconazole) in the Treatment of Endogenous Cushing s Syndrome (Phase III) - ES (completed)

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Cortendo ab
    • Phase : III
  • Principal investigator of clinical trial

  • Dr Carmen FAJARDO
  • Servicio de Endocrinologa
  • Hospital Universitario de La Ribera
  • Carretera de Corbera, Km. 1
  • 46600 ALZIRA
  • SPAIN
  • More information
  • Phone  : 34 962 458 100
  • Fax  : -
  • Website
Last update: April 2020

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.